Therapeutic monitoring in patients receiving sodium nitroprusside therapy. Screen for thiocyanate poisoning.
Plain Red, Lavender (K2EDTA), Lavender (K3EDTA), or Pink (K2EDTA).
Separate from cells ASAP or within 2 hours of collection. Transfer 1 mL serum or plasma to an ARUP Standard Transport Tube. (Min: 0.5 mL)
Whole blood. Gel Separator Tubes, Light Blue (Sodium Citrate), or Yellow (SPS or ACD Solution).
Ambient: 5 days; Refrigerated: 5 days; Frozen: 5 days
Effective May 15, 2017
Nonsmoker: Less than or equal to 4 µg/mL
Smoker: 3-12 µg/mL
Toxic: Greater than 50 µg/mL
Values seen with nitroprusside therapy: 6-29 µg/mL
The therapeutic range is based on serum pre-dose (trough) draw at steady-state concentration.
No compliance statements are in use for this test.
|Component Test Code*||Component Chart Name||LOINC|
- Nipride, Metabolite of
- Nitropress Administration
- Nitroprusside Metabolite
- Sodium Nitroprusside